Drugmakers argue that they've pumped millions into research and so they can charge a lot more for drugs that used to be available cheaply. But experts find flaws in their logic. In other pharmaceutical news: the price of insulin and CVS' fourth-quarter profits.
from Kaiser Health News https://ift.tt/3bBFvDZ
February 13, 2020
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Hospices Have Become Big Business for Private Equity Firms, Raising Concerns About End-of-Life CareHospice care, once provided primarily by nonprofit agencies, has seen a remarkable shift over the past decade, with more than two-thirds of hospices nationwide now operating as for-profit entities. The ability to turn a quick… Read More
Nursing Homes Are Suing the Friends and Family of Residents to Collect DebtsROCHESTER, N.Y. — Lucille Brooks was stunned when she picked up the phone before Christmas two years ago and learned a nursing home was suing her. “I thought this was crazy,” recalled Brooks, 74, a retiree who lives with her … Read More
Citing a Mental Health Crisis Among Young People, California Lawmakers Target Social MediaKarla Garcia said her son’s social media addiction started in fourth grade, when he got his own computer for virtual learning and logged on to YouTube. Now, two years later, the video-sharing site has replaced both schoolwork… Read More
Journalists Detail the Scope of the Abortion Ruling, Monkeypox, and Public Health PowersKHN chief Washington correspondent Julie Rovner discussed the impact of the Supreme Court decision on abortion on SiriusXM’s “The Briefing With Steve Scully” on July 28. Click here to hear Rovner on “The Briefing With S… Read More
What the Polio Case in New York Tells Us About the End of PolioNo one studying polio knew more than Albert Sabin, the Polish-American scientist whose vaccine against the crippling disease has been used worldwide since 1959. Sabin’s oral vaccine provides lifelong immunity. It has one draw… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment